Lithium Controlled-Release and Extended-Release Tablets and Pyrimethamine
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Pyrimethamine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: pyrimethamine
Brand name: Daraprim
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Pyrimethamine and sulfadoxine
- Lithium Controlled-Release and Extended-Release Tablets-Pyrophosphate Injection
- Pyrimethamine-Lithium ER
- Pyrimethamine-Lithium Oral Solution
- Pyrimethamine-Lithium Salts
- Pyrimethamine-Lithium Syrup and Oral Solution
- Pyrimethamine-Lithobid
- Pyrimethamine-Lithostat